Stockscreener 앱 받기
3.32
2.15%
0.07
전일 마감가:
$3.25
열려 있는:
$3.21
하루 거래량:
38,373
Relative Volume:
0.01
시가총액:
$1.77M
수익:
$1.31M
순이익/손실:
$-7.47M
주가수익비율:
-0.4604
EPS:
-7.2117
순현금흐름:
$-5.11M
1주 성능:
-12.40%
1개월 성능:
-30.11%
6개월 성능:
+1,049%
1년 성능:
+1,324%
1일 변동 폭
$3.20
$3.4025
1주일 범위
$3.20
$3.85
52주 변동 폭
$0.197
$8.90
Scisparc Ltd Stock (SPRC) Company Profile
SPRC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRC
Scisparc Ltd
|
3.32 | 5.27M | 1.31M | -7.47M | -5.11M | -7.2117 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Scisparc Ltd 주식(SPRC)의 최신 뉴스
How SciSparc Ltd. stock performs in interest rate cyclesJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
Heatmap analysis for SciSparc Ltd. and competitorsJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Is SciSparc Ltd. stock entering bullish territory2025 Big Picture & Low Risk Entry Point Tips - newser.com
Will SciSparc Ltd. bounce back from current supportQuarterly Portfolio Report & Real-Time Market Sentiment Reports - newser.com
Live market analysis of SciSparc Ltd.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Tools to monitor SciSparc Ltd. recovery probabilityVolume Spike & Weekly High Momentum Picks - newser.com
Is SciSparc Ltd. stock a top momentum playJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Scisparc Ltd (SPRC) Stock Price, News & Analyst Forecast - eToro
N2OFF (NASDAQ: NITO) closes MitoCareX merger; issues 40% of fully diluted shares - Stock Titan
Is SciSparc Ltd. stock in correction or buying zoneWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
SciSparc’s SCI-110 Study: A Potential Game-Changer for Tourette Syndrome - TipRanks
SciSparc gets Nasdaq extension to regain compliance - MSN
SciSparc Ltd. stock retracement – recovery analysis2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
What dividend safety score for SciSparc Ltd. stockJuly 2025 Closing Moves & Fast Moving Stock Watchlists - fcp.pa.gov.br
Is SciSparc Ltd. stock attractive for passive investorsJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará
SciSparc’s Promising Clinical Study on SCI-210 for Autism Spectrum Disorder - TipRanks
SciSparc Completes Acquisition of Neurothera Labs Inc. - TipRanks
Form 6-K: SciSparc finalizes TSXV deal, pharma portfolio moved - Stock Titan
SciSparc Completes Sale of MitoCareX to N2OFF, Enhancing Cancer Drug Discovery - MSN
Scisparc Ltd (SPRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):